+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

From
From
Guillain-Barre Syndrome Market - Global Forecast 2025-2032 - Product Thumbnail Image

Guillain-Barre Syndrome Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 193 Pages
  • Global
From
From
From
From
Global Blood Plasma Products Market (2018-2023) - Product Thumbnail Image

Global Blood Plasma Products Market (2018-2023)

  • Report
  • June 2019
  • 71 Pages
  • Global
From
Complement C1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C1 Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pathogen Reduction Systems Market Report and Forecast 2024-2032 - Product Thumbnail Image

Pathogen Reduction Systems Market Report and Forecast 2024-2032

  • Report
  • October 2024
  • 200 Pages
  • Global
From
Immunoprotein Market - Global Forecast 2025-2032 - Product Thumbnail Image

Immunoprotein Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 186 Pages
  • Global
From
From
Loading Indicator